NPs Basic Information

Name
Androstan-17-one, 3-ethyl-3-hydroxy-, (5alpha)-
Molecular Formula C21H34O2
IUPAC Name*
(5S,8R,9S,10S,13S,14S)-3-ethyl-3-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one
SMILES
CCC1(CC[C@]2([C@H](C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)C)O
InChI
InChI=1S/C21H34O2/c1-4-21(23)12-11-19(2)14(13-21)5-6-15-16-7-8-18(22)20(16,3)10-9-17(15)19/h14-17,23H,4-13H2,1-3H3/t14-,15-,16-,17-,19-,20-,21?/m0/s1
InChIKey
SPKGPDRGORWGNP-SISSWOJJSA-N
Synonyms
3-Ethyl-3-hydroxy-5alpha-androstan-17-one; Androstan-17-one, 3-ethyl-3-hydroxy-, (5.alpha.)-; SCHEMBL22090606; 3-Ethyl-3-hydroxyandrostan-17-one #; 57344-99-7
CAS NA
PubChem CID 14681481
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Steroids and steroid deri
        • Subclass: Androstane steroids
          • Direct Parent: Androgens and derivatives

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 318.5 ALogp: 4.4
HBD: 1 HBA: 2
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 37.3 Aromatic Rings: 4
Heavy Atoms: 23 QED Weighted: 0.724

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.646 MDCK Permeability: 0.00001800
Pgp-inhibitor: 0.993 Pgp-substrate: 0.061
Human Intestinal Absorption (HIA): 0.003 20% Bioavailability (F20%): 0.026
30% Bioavailability (F30%): 0.6

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.34 Plasma Protein Binding (PPB): 88.18%
Volume Distribution (VD): 1.123 Fu: 3.90%

ADMET: Metabolism

CYP1A2-inhibitor: 0.078 CYP1A2-substrate: 0.625
CYP2C19-inhibitor: 0.064 CYP2C19-substrate: 0.855
CYP2C9-inhibitor: 0.12 CYP2C9-substrate: 0.068
CYP2D6-inhibitor: 0.019 CYP2D6-substrate: 0.073
CYP3A4-inhibitor: 0.94 CYP3A4-substrate: 0.718

ADMET: Excretion

Clearance (CL): 21.801 Half-life (T1/2): 0.389

ADMET: Toxicity

hERG Blockers: 0.497 Human Hepatotoxicity (H-HT): 0.491
Drug-inuced Liver Injury (DILI): 0.248 AMES Toxicity: 0.014
Rat Oral Acute Toxicity: 0.449 Maximum Recommended Daily Dose: 0.912
Skin Sensitization: 0.919 Carcinogencity: 0.734
Eye Corrosion: 0.433 Eye Irritation: 0.471
Respiratory Toxicity: 0.977
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003083 0.432 D04DJN 0.500
ENC001029 0.426 D0U3GL 0.488
ENC001197 0.407 D0K0EK 0.482
ENC005141 0.379 D0Q6NZ 0.461
ENC005144 0.379 D06XMU 0.447
ENC003458 0.374 D00VZZ 0.438
ENC005239 0.374 D0Z1XD 0.437
ENC002882 0.374 D07BSQ 0.422
ENC001764 0.374 D08QKJ 0.419
ENC005068 0.363 D09NNA 0.417
*Note: the compound similarity was calculated by RDKIT.